IBIO · iBio, Inc. · Executive Compensation
$0.77
+0.06 (+8.47%)
At close · Oct 27
Return incl. dividend (before tax)
Q4 2022 earnings call transcript
Going-concern doubt
— cleared Aug 28, 2026
The latest filing states the doubt was alleviated.
“The history of significant losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations in the past raised substantial doubt about the Company's ability to continue as a going concern. In August 2025, the Company closed an underwritten public offering raising gross proceeds of approximately $50 million and in January 2026, the Company raised gross proceeds of approximately $26 million in a private placement. Additionally, the Company received gross proceeds of approximately $33.4 million from the exercise of warrants during the year ended June 30, 2026. Based on the total cash and cash equivalents, and investments in debt securities of approximately $88 million at June 30, 2026, the Company believes that its current cash position is sufficient to fund its operations for at least 12 months from the date of filing this Annual Report on Form 10-K for the year ended June 30, 2026 (the “Annual Report”).”View the 10-K filed Aug 28, 2026
Market Cap
$49.32M
Shares
64.31M
Volume · Oct 27
478.17K
Avg daily vol (3M)
731.98K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Thomas Isett | Executive Chairman, President and Chief Executive Officer | $4,839,712 |
| Randy J Maddux | Chief Operating Officer | $1,518,082 |
| DR. MARTIN BRENNER | Chief Scientific Officer | $1,014,282 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Thomas Isett | Executive Chairman, President and Chief Executive Officer | $1,763,224 |
| DR. MARTIN BRENNER | Chief Scientific Officer | — |
| Randy J Maddux | Chief Operating Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Robert B. Kay | Executive Chairman and Chief Executive Officer | $347,604 |
| James P. Mullaney | Chief Financial Officer | $319,167 |
| Robert L. Erwin | President | $275,000 |
| Terence E. Ryan | Chief Scientific Officer | $200,000 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Robert B. Kay | Executive Chairman and Chief Executive Officer | $314,899 |
| Robert L. Erwin | President | $251,666 |
| James P. Mullaney | Chief Financial Officer | $240,000 |
| Terence E. Ryan | Chief Scientific Officer | $200,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Gary Sender | Class III director | Appointed | 2026-10-19 |
| William Clark | Class III director | Appointed | 2026-10-19 |
| Molly Carr | Chief Medical Officer | Appointed | 2026-08-04 |
| Molly Carr, M.D. | Chief Medical Officer | Appointed | 2026-08-04 |
| Evert Schimmelpennink | member of the Board | Resigned | 2026-05-08 |
| Dr. Elizabeth Stoner | Class II director | Appointed | 2026-05-08 |
| Gary Sender | Class III director | Appointed | 2023-11-28 |
| William D. Clark | Class III director | Appointed | 2023-11-28 |
| Felipe Duran | Chief Financial Officer | Appointed | 2023-06-27 |
| Dr. Martin Brenner | Chief Executive Officer | Appointed | 2023-06-27 |
| Felipe Duran | Interim Chief Financial Officer | Appointed | 2023-01-25 |
| Dr. Martin Brenner | Interim Chief Executive Officer | Appointed | 2023-01-25 |
| Robert Lutz | Chief Financial and Business Officer | Resigned | 2023-01-17 |
| Robert Lutz | Chief Financial and Business Officer (member of the office of the Chief Executive Officer) | Appointed | 2022-12-02 |
| Martin Brenner | Chief Scientific Officer (member of the office of the Chief Executive Officer) | Appointed | 2022-12-02 |
| Thomas F. Isett | member of the Board of Directors | Resigned | 2022-12-02 |
| Thomas F. Isett | Chief Executive Officer | Resigned | 2022-12-02 |
| Chip Clark | Chairman of the Board | Appointed | 2022-11-03 |
Leadership
- DR. MARTIN BRENNER CEO, Board Member
- Thomas F. Isett 3rd CEO, Chairman
- Chip Clark Chairman
- Felipe Duran CFO
- Robert M. Lutz CFO
- Randy J. Maddux COO
- John Delta Chief Accounting Officer
- ANT ó NIO PARADA Board Member
- DR. ALEXANDRA KROPOTOVA Board Member
- David Arkowitz Board Member
- Dr. Elizabeth Stoner Board Member
- Dr. Elizabeth Stoner, M.D., M.S. Board Member
- Dr. Linda Armstrong Board Member
- Evert B. Schimmelpennink Board Member
- GARY SENDER Board Member
- John D. McKey, Jr. Board Member
- Philip K Russell, M.D. Board Member
- Seymour Flug Board Member
- William Clark Board Member
- William D. (Chip) Clark Board Member